Novartis Investigative Site

Doetinchem 7009 BL

0 studies enrolling now · 4 studies all time

What they study most

Atherosclerosis, Breast Neoplasms, Cardiovascular Disease, Heart Failure With Preserved Ejection Fraction, Type 2 Diabetes Mellitus

Studies at this site

• A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients — Completed
• Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early